Effects of peroxovanadate complexes on reducing glycemia in diabetic rats and translocation of glucose transporter

Chinese Medical Journal

Volumn 110, Issue 9, 1997, Pages 715-719

  Yuan, Minsheng ^a   Yu, Binjie ^a   Liang, Yiquan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; GLUCOSE TRANSPORTER; NICOTINIC ACID; VANADATE SODIUM; VANADYL DERIVATIVE; VANADYL SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; COMPLEX FORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOBLOTTING; MALE; MICROSOME MEMBRANE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SKELETAL MUSCLE; STREPTOZOCIN DIABETES;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CHELATING AGENTS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HYPOGLYCEMIC AGENTS; MALE; NIACIN; RATS; RATS, SPRAGUE-DAWLEY; VANADATES;

EID: 9844221405     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Burton SD, Ishida T. Effects of insulin and potassium on glucose movement in perfused rat liver. Am J Physiol 1965; 209:1145.
2. Shechter Y, Karlish SJD. Insulin-like stimulation of glucose oxidationin rat adipocytes by vanadyl (IV) ions. Nature 284:556.
3. Shechter Y, Ron A. Effect of depletion of phosphate and bicarbonations on insulin action in rat adipocytes. J Biol Chem 1986; 261(32):14945.
4. Green A. The insulin-like effect of sodium vanadate on adipocyteglucose transport is mediated at post-insulin receptor level. Biochem J 1986; 238:665.
5. Brichard SM, Pttier AM, Henquin JC. Long-term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology 1989; 125:2510.
6. Shechter Y. Insulin mimetic effects of vanadate possible implications of future treatment of diabetes. Diabetes 1990; 39 (1):1.
7. Posner BI. The pathophysiology of diabetes. Tips 1991; 11:343.
8. Foot E, Bliss T, Fernandes LC. The effects of orthovanadate, vanadyl and peroxides of vanadate on glucose metabolism in skeletal muscle preparations in vitro. Mol Cell Biochem 1992; 109:157.
9. Leighton B, Cooper GJS, Dacosta C, et al. Peroxovanadate has full insulin-like effects on glycogen synthesis in normal and insulin-resistant skeletal muscle. Biochem J 1991; 276:289.
10. Speca AN, Gelfand LL. Nicotinate N-Oxida complexes with dipositive 3d-metal ions. Inorganic Chemistry 1976; 15:1493.
11. Hirshman MF, Goodyear LJ, Wardzala LJ, et al. Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle. J Biol Chem 1990; 265(2):987.
12. Shishena A, Inkonomov O, Shechter Y. The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats. Endocrinology 1995; 134:507.
13. Bevan PA, Burgess JW, Yale JF, et al. In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency. Am J Physiol 1995; 268:E60.
14. Domingo JI, Gomez M, Llobet JM, et al. Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is companied by negative side effects. Pharmacol Toxicol 1991; 68:249.
15. Domingo JI, Gomez M, Llobet JM, et al. Oral vanadium adiministration to streptozotocin-diabetic rats has marked negativeside effects which are independent of the form of vanadium used. Toxicology 1991; 66:279.
16. Yale JF, Lachance D, Bevan AP, et al. Hypoglycemic effects of peroxovanadium compound in SD and diabetic BB rats. Diabetes 1995; 44:1274.